U S PHYSICAL THERAPY INC /NV Gain (Loss) on Sale of Interest in Projects
U S PHYSICAL THERAPY INC /NV (USPH) reported Gain (Loss) on Sale of Interest in Projects of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-02-28.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnSaleOfInterestInProjects · last filed 2023-02-28
- U S PHYSICAL THERAPY INC /NV gain (loss) on sale of interest in projects for the quarter ending 2021-12-31 was $0.00.
- U S PHYSICAL THERAPY INC /NV gain (loss) on sale of interest in projects for the quarter ending 2021-09-30 was $0.00, a 100.00% decline year-over-year.
- U S PHYSICAL THERAPY INC /NV gain (loss) on sale of interest in projects for the quarter ending 2021-06-30 was $0.00, a 100.00% decline year-over-year.
- U S PHYSICAL THERAPY INC /NV gain (loss) on sale of interest in projects for the quarter ending 2020-12-31 was $0.00.
- U S PHYSICAL THERAPY INC /NV gain (loss) on sale of interest in projects for fiscal 2022 was $0.00.
- U S PHYSICAL THERAPY INC /NV gain (loss) on sale of interest in projects for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- U S PHYSICAL THERAPY INC /NV gain (loss) on sale of interest in projects for fiscal 2020 was $1.09M, a 80.21% decline from fiscal 2019.
- U S PHYSICAL THERAPY INC /NV gain (loss) on sale of interest in projects for fiscal 2019 was $5.51M.
| Period end | Gain (Loss) on Sale of Interest in Projects 3 month | Gain (Loss) on Sale of Interest in Projects 6 month | Gain (Loss) on Sale of Interest in Projects 9 month | Gain (Loss) on Sale of Interest in Projects 12 month |
|---|---|---|---|---|
| 2022-12-31 | $0.00 10-K · filed 2023-02-28 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $0.00 derived: sum of 2 quarters · filed 2023-02-28 | $0.00 derived: sum of 3 quarters · filed 2023-02-28 | $0.00 10-K · filed 2023-02-28 |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-09 | $0.00 derived: sum of 2 quarters · filed 2021-11-09 | $0.00 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $0.00 10-Q · filed 2021-08-09 | $0.00 10-Q · filed 2021-08-09 | ||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $18.00K derived: sum of 2 quarters · filed 2023-02-28 | $1.09M derived: sum of 3 quarters · filed 2023-02-28 | $1.09M 10-K · filed 2023-02-28 |
| 2020-09-30 | $18.00K 10-Q · filed 2021-11-09 | $1.09M derived: sum of 2 quarters · filed 2021-11-09 | $1.09M 10-Q · filed 2021-11-09 | |
| 2020-06-30 | $1.07M 10-Q · filed 2021-08-09 | $1.07M 10-Q · filed 2021-08-09 | ||
| 2019-12-31 | -$309.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$309.00K derived: sum of 2 quarters · filed 2022-03-01 | $5.51M derived: sum of 3 quarters · filed 2022-03-01 | $5.51M 10-K · filed 2022-03-01 |
| 2019-09-30 | $0.00 10-Q · filed 2020-11-06 | $5.82M derived: sum of 2 quarters · filed 2020-11-06 | $5.82M 10-Q · filed 2020-11-06 | |
| 2019-06-30 | $5.82M 10-Q · filed 2020-08-07 | $5.82M 10-Q · filed 2020-08-07 | ||
| 2018-12-31 | $0.00 10-K · filed 2021-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |